ID

39085

Description

Study to Learn if 200mg Test Drug (Fostamatinib) Helps People With Large B-Cell Lymphoma,a Type of Blood Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01499303

Lien

https://clinicaltrials.gov/show/NCT01499303

Mots-clés

Versions (1)
  1. 29/11/2019 29/11/2019 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

29 novembre 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Diffuse Large B-Cell Lymphoma NCT01499303

Anglais

Eligibility Diffuse Large B-Cell Lymphoma NCT01499303

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
aged at least 18 years of age.
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
patients with relapsed or refractory diffuse large b-cell lymphoma who have previously received r-chop (or equivalent) chemo-immunotherapy and high dose chemotherapy with stem cell rescue, or who are ineligible for high dose therapy with stem cell rescue.
Description

Diffuse large B-cell lymphoma recurrent | Diffuse large B-cell lymphoma refractory | R-CHOP Regimen | Equivalent | High-Dose Chemotherapy with Autologous Stem Cell Transplant | Patients Ineligible High-Dose Chemotherapy with Autologous Stem Cell Transplant

Type de données

boolean

Alias
UMLS CUI [1]
C0855111
UMLS CUI [2]
C0855112
UMLS CUI [3]
C0393023
UMLS CUI [4]
C0205163
UMLS CUI [5]
C1512429
UMLS CUI [6,1]
C0030705
UMLS CUI [6,2]
C1512714
UMLS CUI [6,3]
C1512429
measurable disease as defined by cheson et al 2007 criteria.
Description

Measurable Disease

Type de données

boolean

Alias
UMLS CUI [1]
C1513041
one fresh pre-treatment excisional or core needle biopsy from suitable and accessible site.
Description

Pre treatment Excision biopsy Site Suitable | Pre treatment Core needle biopsy Site Suitable

Type de données

boolean

Alias
UMLS CUI [1,1]
C2709094
UMLS CUI [1,2]
C0184921
UMLS CUI [1,3]
C1515974
UMLS CUI [1,4]
C3900053
UMLS CUI [2,1]
C2709094
UMLS CUI [2,2]
C1318309
UMLS CUI [2,3]
C1515974
UMLS CUI [2,4]
C3900053
world health organization (who) performance status 0 to 1.
Description

WHO performance status scale

Type de données

boolean

Alias
UMLS CUI [1]
C1298650
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
treatment with nitrosurea, mitomycin c, investigational agents or study drugs w/in28 days of first dose of study treatment, any other chemotherapy, immunotherapy or anticancer agents w/in 3 weeks of first dose of study treatment, previous fostamatinib.
Description

Nitrosourea | Mitomycin | Investigational New Drugs | Chemotherapy | Immunotherapy | Antineoplastic Agents | fostamatinib

Type de données

boolean

Alias
UMLS CUI [1]
C0028210
UMLS CUI [2]
C0002475
UMLS CUI [3]
C0013230
UMLS CUI [4]
C0392920
UMLS CUI [5]
C0021083
UMLS CUI [6]
C0003392
UMLS CUI [7]
C2713632
with the exception of alopecia, any unresolved toxicities from prior therapy or surgery greater than common terminology criteria for adverse events (ctcae) grade 1.
Description

Exception Alopecia | Prior Therapy Resulting in Toxicity CTCAE Grades | Operative Surgical Procedures Resulting in Toxicity CTCAE Grades | Resolution Lacking

Type de données

boolean

Alias
UMLS CUI [1,1]
C1705847
UMLS CUI [1,2]
C0002170
UMLS CUI [2,1]
C1514463
UMLS CUI [2,2]
C0332294
UMLS CUI [2,3]
C0600688
UMLS CUI [2,4]
C1516728
UMLS CUI [3,1]
C0543467
UMLS CUI [3,2]
C0332294
UMLS CUI [3,3]
C0600688
UMLS CUI [3,4]
C1516728
UMLS CUI [4,1]
C1514893
UMLS CUI [4,2]
C0332268
uncontrolled hypertension (defined as >140mmhg systolic and/or > 90 mmhg diastolic at baseline with or without antihypertensive therapy.
Description

Uncontrolled hypertension | Systolic Pressure | Diastolic blood pressure | Antihypertensive therapy | Antihypertensive therapy Absent

Type de données

boolean

Alias
UMLS CUI [1]
C1868885
UMLS CUI [2]
C0871470
UMLS CUI [3]
C0428883
UMLS CUI [4]
C0585941
UMLS CUI [5,1]
C0585941
UMLS CUI [5,2]
C0332197
evidence of tuberculosis (tb).
Description

Tuberculosis

Type de données

boolean

Alias
UMLS CUI [1]
C0041296
inadequate boen marrow reserve.
Description

Few mature neutrophils in the bone marrow

Type de données

boolean

Alias
UMLS CUI [1]
C2748959
Retour au début de la page

Similar models

Eligibility Diffuse Large B-Cell Lymphoma NCT01499303

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
aged at least 18 years of age.
boolean
C0001779 (UMLS CUI [1])
Diffuse large B-cell lymphoma recurrent | Diffuse large B-cell lymphoma refractory | R-CHOP Regimen | Equivalent | High-Dose Chemotherapy with Autologous Stem Cell Transplant | Patients Ineligible High-Dose Chemotherapy with Autologous Stem Cell Transplant
Item
patients with relapsed or refractory diffuse large b-cell lymphoma who have previously received r-chop (or equivalent) chemo-immunotherapy and high dose chemotherapy with stem cell rescue, or who are ineligible for high dose therapy with stem cell rescue.
boolean
C0855111 (UMLS CUI [1])
C0855112 (UMLS CUI [2])
C0393023 (UMLS CUI [3])
C0205163 (UMLS CUI [4])
C1512429 (UMLS CUI [5])
C0030705 (UMLS CUI [6,1])
C1512714 (UMLS CUI [6,2])
C1512429 (UMLS CUI [6,3])
Measurable Disease
Item
measurable disease as defined by cheson et al 2007 criteria.
boolean
C1513041 (UMLS CUI [1])
Pre treatment Excision biopsy Site Suitable | Pre treatment Core needle biopsy Site Suitable
Item
one fresh pre-treatment excisional or core needle biopsy from suitable and accessible site.
boolean
C2709094 (UMLS CUI [1,1])
C0184921 (UMLS CUI [1,2])
C1515974 (UMLS CUI [1,3])
C3900053 (UMLS CUI [1,4])
C2709094 (UMLS CUI [2,1])
C1318309 (UMLS CUI [2,2])
C1515974 (UMLS CUI [2,3])
C3900053 (UMLS CUI [2,4])
WHO performance status scale
Item
world health organization (who) performance status 0 to 1.
boolean
C1298650 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Nitrosourea | Mitomycin | Investigational New Drugs | Chemotherapy | Immunotherapy | Antineoplastic Agents | fostamatinib
Item
treatment with nitrosurea, mitomycin c, investigational agents or study drugs w/in28 days of first dose of study treatment, any other chemotherapy, immunotherapy or anticancer agents w/in 3 weeks of first dose of study treatment, previous fostamatinib.
boolean
C0028210 (UMLS CUI [1])
C0002475 (UMLS CUI [2])
C0013230 (UMLS CUI [3])
C0392920 (UMLS CUI [4])
C0021083 (UMLS CUI [5])
C0003392 (UMLS CUI [6])
C2713632 (UMLS CUI [7])
Exception Alopecia | Prior Therapy Resulting in Toxicity CTCAE Grades | Operative Surgical Procedures Resulting in Toxicity CTCAE Grades | Resolution Lacking
Item
with the exception of alopecia, any unresolved toxicities from prior therapy or surgery greater than common terminology criteria for adverse events (ctcae) grade 1.
boolean
C1705847 (UMLS CUI [1,1])
C0002170 (UMLS CUI [1,2])
C1514463 (UMLS CUI [2,1])
C0332294 (UMLS CUI [2,2])
C0600688 (UMLS CUI [2,3])
C1516728 (UMLS CUI [2,4])
C0543467 (UMLS CUI [3,1])
C0332294 (UMLS CUI [3,2])
C0600688 (UMLS CUI [3,3])
C1516728 (UMLS CUI [3,4])
C1514893 (UMLS CUI [4,1])
C0332268 (UMLS CUI [4,2])
Uncontrolled hypertension | Systolic Pressure | Diastolic blood pressure | Antihypertensive therapy | Antihypertensive therapy Absent
Item
uncontrolled hypertension (defined as >140mmhg systolic and/or > 90 mmhg diastolic at baseline with or without antihypertensive therapy.
boolean
C1868885 (UMLS CUI [1])
C0871470 (UMLS CUI [2])
C0428883 (UMLS CUI [3])
C0585941 (UMLS CUI [4])
C0585941 (UMLS CUI [5,1])
C0332197 (UMLS CUI [5,2])
Tuberculosis
Item
evidence of tuberculosis (tb).
boolean
C0041296 (UMLS CUI [1])
Few mature neutrophils in the bone marrow
Item
inadequate boen marrow reserve.
boolean
C2748959 (UMLS CUI [1])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial